Clinical trial

177Lu-labeled NY108 SPECT Imaging in Patients

NCT05815394

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-03-03

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2023-03-03Date precision: day

Registry last updated2023-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

177Lu-labeled NY108DRUG

Sponsors & collaborators

Affiliated Hospital of Jiangnan Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05815394 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.